5EIQ
Human OSCAR ligand-binding domain
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | APS BEAMLINE 24-ID-C |
| Synchrotron site | APS |
| Beamline | 24-ID-C |
| Temperature [K] | 100 |
| Detector technology | CCD |
| Collection date | 2011-11-11 |
| Detector | ADSC QUANTUM 315 |
| Wavelength(s) | 0.97934 |
| Spacegroup name | P 1 21 1 |
| Unit cell lengths | 26.938, 48.486, 74.945 |
| Unit cell angles | 90.00, 91.82, 90.00 |
Refinement procedure
| Resolution | 40.700 - 2.010 |
| R-factor | 0.1808 |
| Rwork | 0.179 |
| R-free | 0.21870 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 3p2t |
| RMSD bond length | 0.010 |
| RMSD bond angle | 1.010 |
| Data reduction software | XDS |
| Data scaling software | SCALA |
| Phasing software | BALBES |
| Refinement software | BUSTER-TNT |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 48.486 | 48.486 | 2.110 |
| High resolution limit [Å] | 2.006 | 6.340 | 2.010 |
| Rmerge | 0.047 | 0.650 | |
| Rmeas | 0.190 | ||
| Rpim | 0.100 | 0.042 | 0.489 |
| Total number of observations | 47065 | 1500 | 6805 |
| Number of reflections | 12996 | ||
| <I/σ(I)> | 7.7 | 18.9 | 1.9 |
| Completeness [%] | 99.1 | 99.4 | 98.4 |
| Redundancy | 3.6 | 3.4 | 3.6 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION | 5 | 277 | 0.1 M NaCitrate pH 5.0, 30% PEG 8000 |






